Published in

American Association for the Advancement of Science, Science Translational Medicine, 371(9), 2017

DOI: 10.1126/scitranslmed.aaf5294

Links

Tools

Export citation

Search in Google Scholar

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

PAR4 inhibition with a reversible small-molecule antagonist is a promising antiplatelet therapy.